How Big is the Women’s Health Market ? :

IMARC Group’s latest report, titled “Women’s Health Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on the women’s health market report. The report also includes competitor and regional analysis, and contemporary advancements in the market. the global women’s health market size reached US$ 39.32 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 51.65 Billion by 2028, exhibiting a growth rate (CAGR) of 4.33% during 2023-2028.

What is Women’s Health ? :

Women’s health encompasses the physical, mental, and social well-being of women throughout their lifespan. It addresses the unique health concerns and needs that are specific to women. It encompasses a wide range of medical, social, and psychological aspects, aiming to promote and enhance women’s overall well-being. Reproductive health is a crucial aspect of women’s health, encompassing menstrual health, family planning, contraception, fertility, and pregnancy-related care.

Maternal health focuses on the well-being of women during pregnancy, childbirth, and the postpartum period. Breast health plays a significant role in women’s health, including regular screenings for breast cancer and access to diagnostic and treatment services. Sexual health is another essential component, encompassing aspects such as sexual education, contraception, sexually transmitted infection prevention, and the management of sexual dysfunction. Women’s health also includes addressing the prevalence and impact of gender-based violence, domestic abuse, and sexual assault, as these factors significantly impact women’s overall well-being.

Request Free Sample Report (Exclusive Offer on this report):

Who are the key Players Operating in the Industry ? :

  • Abbott Laboratories
  • AbbVie Inc
  • Agile Therapeutics Inc
  • Amgen Inc
  • Bayer AG
  • Hoffmann-La Roche AG
  • Ferring Pharmaceuticals
  • FUJIFILM Holdings Corporation
  • Hologic Inc
  • Lupin Limited
  • Novo Nordisk A/S
  • Pfizer Inc

What are the Growth Prospects and Trends in the Women’s Health Industry ? :

The increasing focus on preventive care is driving the global market. Moreover, the implementation of screening programs, diagnostic tools, and educational campaigns to raise awareness and empower women to take proactive steps toward maintaining their health is supporting the market. Apart from this, ongoing advancements in reproductive technologies, such as assisted reproductive technologies (ART), including in-vitro fertilization (IVF), provide hope and options for women and couples struggling with reproductive challenges is providing a boost to the market.

Additionally, continual advancements in prenatal diagnostics, genetic screening, and fetal monitoring have improved the care and outcomes for pregnant women and their babies, thus contributing to the market. Besides, the rising demand for women-centric healthcare services is further propelling the market as these centers provide comprehensive care for conditions such as polycystic ovary syndrome (PCOS), endometriosis, and hormonal imbalances.

Women’s Health Development:

Furthermore, the development of mobile applications, wearable devices, and telemedicine platforms enable women to track their menstrual cycles, monitor fertility, and access virtual consultations with healthcare providers is creating a positive market outlook since these technological innovations enhance convenience, improve patient engagement, and facilitate remote monitoring and support. Along with this, several leading players are focusing on extensive research and development of innovative drugs, therapies, and medical devices targeting women’s health conditions, catalyzing overall growth.

Moreover, the escalating prevalence of chronic diseases such as breast cancer, cervical cancer, endometriosis, polycystic ovary syndrome (PCOS), and reproductive disorders strengthens the demand for improved diagnostics, treatment options, and long-term management in the women’s health market. Apart from this, favorable insurance coverage and reimbursement policies for women’s health services, including screenings, preventive care, and treatments, are projected to propel the market further.

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure:

Key Market Segmentation: 

Age Group Type Insights:

  • 50 Years and Above 
    • Postmenopausal Osteoporosis
    • Endometriosis and Uterine Fibroids
    • Menopause
  • Others

Application Insights:

  • Contraceptives
  • Osteoporosis
  • Menopause
  • Infertility
  • Others

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other) 

Key Highlights of the Report: 

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

Related Report By IMARC Group:

About Us: 

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. 

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. 

Tags: , , , , ,

See Campaign:

Contact Information:

Contact us: IMARC Group 134 N 4th St. Brooklyn, NY 11249, USA Email: [email protected] Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

IPS, iCN Internal Distribution, Extended Distribution, Research Newswire, English